Course Description:
This webinar series will update you on the latest USP developments in Particulate Matters.
The series will focus on USP General Chapters <1>, <790> and <1790>, which address particles observed in injections in the visible range. Specific methods and requirements will be reviewed and compared with similar expectations found in the European and Japanese Pharmacopeias. Also included is a discussion about the recently released draft guidance from FDA titled Inspection of Injectable Products for Visible Particles.
Who should participate:
- Laboratory scientists
- Lab managers
- QA/QC staff in the pharmaceutical and allied industries
- Regulatory professionals
- Scientists with interest in Particulate Matter
The live version of this recording took place on May 12, 2022.
Access Duration:Access to this course expires 60 days from the date of registration or until you mark the course ‘Complete’ – whichever occurs first.
Speakers
D. Scott Aldrich
USP Dosage Forms Expert Committee
B.S., Western Michigan University
Desmond Hunt
Senior Scientist III, India, USP
Senior Scientific Liaison, USP
Ph.D., University of Texas, Austin, USA
John G. Shabushnig, Ph.D.
USP Dosage Forms Expert Committee
B.S., Chemistry, Carroll College
Ph.D., Analytical Chemistry, Indiana University